Seeing Is Believing
Currently out of the existing stock ratings of Tazeen Ahmad, 204 are a BUY (66.02%), 70 are a HOLD (22.65%), 35 are a SELL (11.33%).
Analyst Tazeen Ahmad, currently employed at BAML, carries an average stock price target met ratio of 57.8% that have a potential upside of 27.77% achieved within 159 days.
Tazeen Ahmad’s has documented 623 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on PTCT, PTC Therapeutics at 20-Feb-2026.
Analyst best performing recommendations are on SRZN (SURROZEN).
The best stock recommendation documented was for SRZN (SURROZEN) at 11/17/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.65 (9.91%) receiving and performance score of 99.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Dec-2021
$23
$-0.99 (-4.13%)
$22
17 days ago
(06-Feb-2026)
17/17 (100%)
$-0.56 (-2.38%)
84
Buy Since 26-Jun-2025
$31
$7.01 (29.22%)
$32
20 days ago
(03-Feb-2026)
0/5 (0%)
$6.24 (25.20%)
Buy Since 21-Oct-2025
$36
$12.01 (50.06%)
$33
1 months 17 days ago
(06-Jan-2026)
0/2 (0%)
$9.06 (33.63%)
Buy Since 17-Oct-2023
$40
$16.01 (66.74%)
$39
1 months 17 days ago
(06-Jan-2026)
2/7 (28.57%)
$13.06 (48.48%)
467
Hold Since 03-Nov-2022
$25
$1.01 (4.21%)
2 months 12 days ago
(11-Dec-2025)
18/21 (85.71%)
$-1.68 (-6.30%)
118
Which stock is Tazeen Ahmad is most bullish on?
Which stock is Tazeen Ahmad is most reserved on?
What Year was the first public recommendation made by Tazeen Ahmad?